Delcath Systems (DCTH) Total Debt Growth (1y) (2011 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.12% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.70% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 15.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -5.48% |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 152.64% |
| Mar 31, 2024 | -49.43% |
| Dec 31, 2023 | -52.01% |
| Sep 30, 2023 | -73.43% |
| Jun 30, 2023 | -56.50% |
| Mar 31, 2023 | -57.30% |
| Dec 31, 2022 | -0.70% |
| Sep 30, 2022 | 51.28% |
| Dec 31, 2021 | 2,777.75% |
| Dec 31, 2020 | -88.66% |
| Dec 31, 2019 | 10,106.06% |
| Sep 30, 2019 | 1,283.73% |
| Jun 30, 2019 | -99.87% |
| Mar 31, 2019 | -99.38% |
| Dec 31, 2018 | -94.11% |
| Sep 30, 2018 | 9,118.75% |
| Jun 30, 2018 | 15,906.98% |
| Mar 31, 2018 | -76.19% |
| Dec 31, 2017 | -97.01% |
| Sep 30, 2017 | -99.93% |
| Jun 30, 2017 | -99.86% |
| Mar 31, 2017 | 753.88% |
| Dec 31, 2016 | 395.40% |
| Sep 30, 2016 | 666.68% |
| Jun 30, 2016 | 3,997.37% |
| Mar 31, 2016 | 145.33% |
| Dec 31, 2015 | 1,582.22% |
| Sep 30, 2015 | 428.83% |
| Jun 30, 2015 | -29.21% |
| Mar 31, 2015 | -65.15% |
| Dec 31, 2014 | -90.26% |
| Sep 30, 2014 | -35.69% |
| Jun 30, 2014 | 193.72% |
| Mar 31, 2014 | -56.26% |
| Dec 31, 2013 | -32.59% |
| Sep 30, 2013 | -81.08% |
| Jun 30, 2013 | -93.81% |
| Mar 31, 2013 | 87.20% |
| Dec 31, 2012 | 40.51% |
| Sep 30, 2012 | 45.21% |
| Jun 30, 2012 | -15.65% |
| Dec 31, 2011 | -86.45% |